The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: Clinical evidence from the physicians' health study
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 122 (6) , 1588-1592
- https://doi.org/10.1016/0002-8703(91)90275-m
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.Circulation, 1989
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Platelets and Prostaglandins in Coronary Artery DiseasePublished by American Medical Association (AMA) ,1983
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregationProstaglandins, 1979
- Inhibition of platelet prostaglandin synthetase by oral aspirin.Journal of Clinical Investigation, 1978
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976